Opendata, web and dolomites

EQUIVert SIGNED

Worldwide unique biofeedback system for non-invasive vertigo therapy and fall prevention

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EQUIVert project word cloud

Explore the words cloud of the EQUIVert project. It provides you a very rough idea of what is the project "EQUIVert" about.

followed    parallel    balance    combination    purchase    position    market    benefits    healthcare    huge    home    caused    treatment    dynamically    complete    until    unfortunately    impossible    human    ease    accumulated    initially    eur    gesture    equivert    turnover    exercises    foreseen    biofeedback    sound    unconscious    possibility    employees    train    medicine    22    right    training    central    ongoing    severe    options    2024    life    shortly    acoustic    give    shortcomings    least    ear    medical    sensory    overcome    otherwise    16    ultimately    disturbance    private    dizziness    guide    professional    once    adapts    physicians    lifetime    anywhere    price    causing    30    ged    organ    properly    form    preinstalled    symptom    patients    audio    total    planning    headphone    device    trainer    time    wrong    ready    everyday    diagnosis    inner    introduction    sensitivity    anytime    compensate    regarding    effectiveness    sensor    hard    individual    expansion    personal    million    provides    registration    worldwide    progress    conscious    brain    vertigo    people   

Project "EQUIVert" data sheet

The following table provides information about the project.

Coordinator
GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH 

Organization address
address: PASTORATSSTRASSE 3
city: RUPPICHTEROTH
postcode: 53809
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH DE (RUPPICHTEROTH) coordinator 50˙000.00

Map

 Project objective

Vertigo (dizziness) is the second most common symptom in medicine, causing 30% of all people worldwide to be treated at least once in their lifetime. It is caused by a disturbance of the balance organ in our inner ear and has a significant impact on our everyday life, making many activities very hard or even impossible. However, through effective balance training, the human brain is capable to compensate for the wrong sensory information and can ultimately overcome vertigo. Unfortunately, current treatment options show severe shortcomings regarding costs, availability, and effectiveness of training. To overcome this problem, GED has developed EQUIVert. EQUIVert is the personal balance trainer for the home and professional use. It is a headphone with integrated position sensor and gesture control. It provides real-time acoustic biofeedback through sound to give the user conscious access to the otherwise unconscious combination of balance and depth sensitivity. EQUIVert is a complete system and ready to use. All exercises and training programmes are already preinstalled in the audio guide and it dynamically adapts the exercises to training progress and individual form. The major benefits for the users are the low purchase price, the effectiveness of the training, the ease of use, and the possibility to train anytime and anywhere. With over 100 million potential patients in Europe and the US, of which most are not or not properly treated right now, EQUIVert has a huge market creating potential. GED is planning a parallel market introduction, addressing private patients with an individual training device and healthcare physicians with a diagnosis support device. Following the already ongoing registration as medical device, EQUIVert will initially be introduced into the Central European market, shortly followed by an expansion across Europe and the US. A total of 22 new employees and an accumulated turnover of EUR 16 million is foreseen until the end of 2024.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EQUIVERT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EQUIVERT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More